GTS Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-175,700
Closed -$1.61M 3794
2024
Q3
$1.61M Buy
175,700
+93,700
+114% +$775K ﹤0.01% 1734
2024
Q2
$802K Buy
82,000
+10,000
+14% +$122K ﹤0.01% 2261
2024
Q1
$1.09M Sell
72,000
-162,400
-69% -$2.95M ﹤0.01% 1925
2023
Q4
$5.05M Sell
234,400
-77,800
-25% -$1.44M 0.01% 997
2023
Q3
$5.8M Buy
+312,200
New +$7.29M 0.01% 858

Other funds holding TDOC

GTS Securities's TDOC Position: Q3 2024 in Review

GTS Securities sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 32,078 shares — an estimated $265K sold.

GTS Securities first reported a position in TDOC in Q2 2023 and held it in 5 quarters. The position peaked at $2.47M in Q4 2023. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • GTS Securities reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 32,078 Teladoc Health shares in Q3 2024, an estimated $265K.
  • GTS Securities first reported a position in Teladoc Health in Q2 2023 and held it in 5 quarters.
  • GTS Securities's Teladoc Health position peaked at $2.47M in Q4 2023.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.